Dr. Bhatia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 Doughty St
Roper Medical Office Building
Charleston, SC 29403
Education & Training
Topiwala National Medical CollegeClass of 2005
Medical University of South CarolinaResidency, Child Neurology- Medical University of South CarolinaFellowship, Epilepsy
Certifications & Licensure
CA State Medical License 2024 - 2027
AK State Medical License 2023 - 2026
NY State Medical License 2005 - 2026
TX State Medical License 2023 - 2026
UT State Medical License 2023 - 2026
AZ State Medical License 2023 - 2025
CO State Medical License 2023 - 2025
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology- American Board of Psychiatry and Neurology Epilepsy
- Join now to see all
Publications & Presentations
PubMed
- Common Data Elements Regarding Social Determinants of Health in Pediatric Epilepsy Research: A Concept Mapping Study.Laura Kirkpatrick, Chethan K Rao, Christopher W Beatty, Sonal Bhatia, Charuta Joshi
Pediatric Neurology. 2025-04-01 - A Multicenter Training and Interrater Reliability Study of the BASED Score for Infantile Epileptic Spasms Syndrome.John R Mytinger, Dara V F Albert, Shawn C Aylward, Christopher W Beatty, Sonam Bhalla
Journal of Clinical Neurophysiology. 2025-03-01 - Antiseizure medications for Lennox-Gastaut Syndrome: Comprehensive review and proposed consensus treatment algorithm.Debopam Samanta, Sonam Bhalla, Sonal Bhatia, Anthony L Fine, Babitha Haridas
Epilepsy & Behavior. 2025-03-01
Press Mentions
- Pfizer Highlights Scientific Advances from Growing Hematology Portfolio at American Society of Hematology Annual MeetingNovember 3rd, 2023
- Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia BApril 30th, 2024
- FDA Approves CDx to Determine Gene Therapy Eligibility for Hemophilia B PatientsApril 30th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
